ACL releases earnings on Oct 20th. Also, either the 21st or 22nd phase III results of RETAANE will be released. RETAANE, like MACUGEN (EYET), treats aged related macular degeneration of the eye. Looks like the run has begun! I am already positioned with Nov. 75 calls.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.